OMGA

Omega Therapeutics (OMGA)

About Omega Therapeutics (OMGA)

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

Details

Daily high

$0.88

Daily low

$0.79

Price at open

$0.80

52 Week High

$6.30

52 Week Low

$0.75

Market cap

46.3M

Dividend yield

0.00%

Volume

180,790

Avg. volume

250,490

P/E ratio

-.63

Omega Therapeutics News